WA
The startup develops alpha nuclear medicine therapy using astatine compounds to target and treat cancer cells with precision. By focusing on low-molecular-weight and antibody-introduced formulations, the company aims to enhance treatment efficacy and minimize side effects for patients undergoing cancer therapy.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops alpha nuclear medicine therapy using astatine compounds to target and treat cancer cells with precision. By focusing on low-molecular-weight and antibody-introduced formulations, the company aims to enhance treatment efficacy and minimize side effects for patients undergoing cancer therapy.